The U.S. Food and Drug Administration (FDA) has approved Portola Pharmaceuticals' Andexxa, the first antidote indicated for patients treated with rivaroxaban (Xarelto) and apixaban (Eliquis), when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding.
May 07, 2018
News
Stereotaxis and Acutus Medical announced a strategic collaboration to integrate the Stereotaxis Niobe Magnetic Navigation System and the Acutus Medical AcQMap High Resolution Imaging and Mapping System. The goal of the collaboration is to improve patient care and the physician experience in electrophysiology.
May 04, 2018
Blog
In March, I made a day trip to New York City to receive the 2017 Jesse H. Neal Award for Best Use of Social Media. The ...
May 04, 2018Sponsored Content
Feature | Nuclear Imaging
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
November 12, 2025
Case Study | Cardiovascular Information Systems (CVIS)
Balancing high quality care with efficiency — and avoiding unnecessary procedures — is a priority for any hospital ...
May 04, 2018
Feature | Heart Valve Technology | Dave Fornell, Editor
May 4, 2018 — Transcatheter valve technology has been advancing very quickly and the links to aggregated content from ...
May 04, 2018
News | Womens Cardiovascular Health
May 3, 2018 — The U.S. Food and Drug Administration (FDA) recently announced the availability of a draft guidance for ...
May 03, 2018Sponsored Content
Feature
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
June 17, 2025
Technology | EP Mapping and Imaging Systems
May 3, 2018 — APN Health LLC announced its Navik 3D mapping system is commercially released and in clinical use. The ...
May 03, 2018
Technology | EP Mapping and Imaging Systems
May 3, 2018 — The U.S. Food and Drug Administration (FDA) has granted market clearance for the Abbott Advisor HD Grid ...
May 03, 2018
Technology | Drug-Eluting Balloons
May 3, 2018 — The U.S. Food and Drug Administration (FDA) has expanded the indication for the Medtronic In.Pact Admiral ...
May 03, 2018Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024Technology | Intravascular Imaging
May 2, 2018 — Conavi Medical Inc. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its ...
May 02, 2018
News | Congenital Heart
Select adult patients born with a single functioning ventricle, and who have undergone a surgical operation called the ‘Fontan procedure’ during childhood, are being enrolled in a new global-first clinical trial. The trial, led by a multi-disciplinary team of heart and lung physicians, will examine the effects of a portable, non-invasive medical device never before tested on patients with this cardiac condition.
May 02, 2018
News | Artificial Intelligence
May 2, 2018 – The Board of Directors of the Radiological Society of North America (RSNA) announced that Charles E. Kahn ...
May 02, 2018Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
360 Photos | Stroke
This is a 360 degree view inside the back of the Northwestern Medicine Central DuPage Hospital Mobile Stroke Unit ...
May 01, 2018
News | Computed Tomography (CT)
James K. Min, M.D., FSCCT, has been selected for a five-year term as the new editor-in-chief of the Journal of Cardiovascular Computed Tomography (JCCT). He in turn has named Todd C. Villines, M.D., FSCCT, as executive editor along with Gudrun Feuchtner, M.D.
May 01, 2018
Technology | CT Angiography (CTA)
Cerebrovascular imaging analysis company iSchemaView received final clearance from the U.S. Food and Drug Administration (FDA) for Rapid CTA, the company’s 3-D imaging solution for computed tomography angiography. Rapid CTA is the newest addition to iSchemaView’s neuroimaging platform — including Rapid CTP and Rapid MRI — which is designed to provide physicians with fast, fully-automated and easy-to-interpret imaging that facilitates clinical decision making around cerebrovascular disease, such as stroke.
May 01, 2018